arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Supernus Pharmaceuticals, Inc.

SUPN Health Care Biotechnology: Pharmaceutical Preparations
$44.75
▲ +0.1% Today
as of Jun 7, 07:28 ET
Last 30 days -8.09% Apr 28 → Jun 05
$43.38 $45.77 $48.16 $50.55 $52.94 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$45.05
High
$45.73
Low
$44.63
Volume
$544,170
Avg Vol
$762,750
Mkt Cap
$2.7B
P/E (TTM)
Beta
52w High
$59.68
52w Low
$30.83
Div Yield
Shares Out
$58M

Overview

52-week range
$31
$60
48% of range
Avg surprise (last 2)
+114.6%
Avg reaction (last 2)
+0.6%
100% positive
Latest IV / EM
45%
EM ±6.3% · $45 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.80$-0.43$-0.06$0.32$0.69 Actual $-0.02Actual $-0.29Actual $0.36Actual $0.69Actual $0.28Est $0.26Actual $0.40Actual $-0.80Actual $0.45Est $0.14 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-45M$-24M$-2M$19M$40M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue May 5, 2026Mar/2026 $0.45 $0.14 +221.4% +60.7% +1.2% earnings
Tue Sep 30, 2025Sep 2025 $-0.80 financials
Mon Jun 30, 2025Jun 2025 $0.40 financials
Tue May 6, 2025Mar/2025 $0.28 $0.26 +7.7% +0.1% earnings
Mon Sep 30, 2024Sep 2024 $0.69 financials
Sun Jun 30, 2024Jun 2024 $0.36 financials
Sun Mar 31, 2024Mar 2024 financials
Sat Sep 30, 2023Sep 2023 $-0.29 financials
Fri Jun 30, 2023Jun 2023 $-0.02 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue$23M$19M$17M$16M$18M$18M
Gross profit
Operating income$-8M$-60M$12M$-10M$41M$23M
Net income$-2M$-45M$22M$-12M$38M$20M
EPS (diluted)$-0.04$-0.80$0.40$-0.21$0.69$0.36

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$185M$128M$151M$145M$116M$69M$32M$52M
Inventory$111M$112M$107M$44M$49M$54M$64M$68M
Total current assets$732M$644M$594M$739M$688M$686M$640M$591M
Total assets$1.50B$1.45B$1.42B$1.38B$1.35B$1.37B$1.34B$1.32B
Long-term debt
Total liabilities$424M$391M$370M$319M$317M$332M$336M$358M
Total equity$1.08B$1.06B$1.05B$1.06B$1.03B$1.04B$1.01B$957M

Implied volatility — last 90 days

40%42%45%47%50% Jun 07 — IV 45% · EM ±6.3%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.